16 completed, 4 recruiting, 4 terminated, 2 unknown. 13 Phase 2, 4 Not applicable, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow Breast Tumors: new trials by email Literature Review of Breast Tumors trials Research Report on Breast Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery HealiAid Collagen Wound Dressing - Breast Tumors, Wound Healing | Not applicable | Recruiting | Maxigen Biotech Inc. | 60 | 2025-05-20 | 2025-10-06 |
| Clinical Study of 18F-FAPI-RGD in Breast Tumors Breast Tumors | Completed | Sichuan Provincial People's Hospital | 30 | 2023-06-20 | 2024-07-15 | |
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study Palbociclib, Ribociclib, Abemaciclib - Breast Adenocarcinoma, Breast Cancer Stage IV | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3500 | 2023-05-01 | 2025-02-03 | |
| Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy Dalpiciclib, Pyrotinib, SHR-A1811 - Breast Neoplasm, Breast Cancer | Phase 2 | Recruiting | Fudan University | 716 | 2022-11-01 | 2026-05-28 |
| Therapeutic Dose Monitoring (TDM) of Tamoxifen Tamoxifen 20 mg - Breast Cancer, Breast Carcinoma | Phase 2 | Unknown | Karolinska University Hospital | 40 | 2022-04-04 | 2022-05-25 |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer Palbociclib plus hormonal treatment - first line treatment, Palbociclib plus hormonal treatment - second line treatment - Breast Cancer, Breast Carcinoma | Completed | Pfizer | 150 | 2021-05-24 | 2023-12-19 | |
| Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis DS-8201a - Breast Tumors | Phase 2 | Completed | UNICANCER | 186 | 2019-10-21 | 2025-06-12 |
| Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound - Breast Cancer, Breast Tumors | Not applicable | Completed | Washington University School of Medicine | 41 | 2016-11-29 | 2021-02-16 |
| Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer Paclitaxel, Alisertib - Breast Cancer, Breast Carcinoma | Phase 2 | Completed | US Oncology Research | 169 | 2015-02-12 | 2024-10-09 |
| A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer Letrozole, palbociclib - Breast Cancer, Breast Carcinoma | Phase 2 | Completed | NSABP Foundation Inc | 307 | 2015-01-01 | 2022-01-13 |
| Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer Metformin, Doxorubicin - Breast Cancer, Breast Tumors | Phase 2 | Terminated | Avera McKennan Hospital & University Health Center | 30 | 2014-07-01 | 2019-10-16 |
| Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer Metformin, Atorvastatin, Breast surgery - Breast Cancer, Breast Tumors | Early Phase 1 | Completed | Columbia University | 23 | 2013-10-01 | 2023-08-30 |
| Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes E7389 (Eribulin Mesylate), Vinorelbine injection - HER2-Negative Breast Cancer, Triple Negative Breast Cancer | Phase 3 | Completed | Eisai Co., Ltd. | 530 | 2013-09-26 | 2018-08-28 |
| Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine levobupivacaine - Breast Tumors, Hypotension | Phase 4 | Active not recruiting | University Hospital Dubrava | 80 | 2013-08-01 | 2026-05-04 |
| Simulated Screening Study for Breast Imaging X-ray and ultrasound imaging scanning, Photoacoustic imaging scans for breast cancer screening - Breast Cysts, Breast Tumors | Completed | University of Michigan | 41 | 2012-12-01 | 2020-05-21 | |
| Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer Eribulin, Doxorubicin, Cyclophosphamide - Breast Neoplasms, Breast Cancer | Phase 2 | Terminated | Emory University | 7 | 2011-11-01 | 2016-10-03 |
| Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors Lapatinib - Brain Metastases, Lung Tumors | Phase 2 | Completed | Hellenic Cooperative Oncology Group | 82 | 2010-10-01 | 2014-12-31 |
| Re-expression of ER in Triple Negative Breast Cancers Decitabine, LBH589, Tamoxifen - Breast Cancer, Breast Tumors | Phase 1 / Phase 2 | Terminated | Emory University | 5 | 2010-07-01 | 2015-01-26 |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin - Breast Neoplasms, Breast Cancer | Phase 2 | Recruiting | QuantumLeap Healthcare Collaborative | 5000 | 2010-03-01 | 2026-05-06 |
| Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer Pralatrexate Injection, Vitamin B12, Folic Acid - Breast Cancer, Breast Tumors | Phase 2 | Completed | Acrotech Biopharma Inc. | 22 | 2010-03-01 | 2020-01-07 |
Showing 20 of 27. Sign in to see all of them.
Breast Neoplasms (27) · Neoplasm Metastasis (4) · Neoplasms (4) · Triple Negative Breast Neoplasms (4) · Bradycardia (1) · Brain Neoplasms (1) · Breast Cyst (1) · Breast Diseases (1) · Breast Neoplasms, Male (1) · Cardiotoxicity (1) · Hemangiosarcoma (1) · Hypotension (1) · Lung Neoplasms (1) · Pathologic Complete Response (1)
Neoplasms by Site (27) · Skin Diseases (27) · Skin and Connective Tissue Diseases (27) · Breast Diseases (26) · Neoplasms (23) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Neoplastic Processes (4) · Cardiovascular Diseases (2) · Heart Diseases (2) · Arrhythmias, Cardiac (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Chemically-Induced Disorders (1)
Paclitaxel (5) · Doxorubicin (3) · Letrozole (3) · Trastuzumab (3) · palbociclib (3) · Carboplatin (2) · Cyclophosphamide (2) · Lapatinib (2) · Metformin (2) · Tamoxifen (2) · abemaciclib (2) · eribulin (2) · ganitumab (2) · pertuzumab (2) · trebananib (2)
Emory University (3) · Amgen (2) · Acrotech Biopharma Inc. (1) · Avera McKennan Hospital & University Health Center (1) · Columbia University (1) · Eisai Co., Ltd. (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Fudan University (1) · Hellenic Cooperative Oncology Group (1) · Karolinska University Hospital (1) · Maxigen Biotech Inc. (1) · NSABP Foundation Inc (1) · NantCell, Inc. (1) · National University Hospital, Singapore (1) · Pfizer (1)
United States (14) · France (5) · China (3) · Canada (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Croatia (1) · Czechia (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Ireland (1) · Italy (1)
Andrzej Krol, PhD (1) · Christos Christodoulou, MD (1) · Elham Hedayati, MD PhD (1) · Garry Weems, PharmD (1) · Ino Husedzinovic, PhD,MD (1) · Joyce A. O'Shaughnessy, MD (1) · Katherine Crew, MD (1) · Keerthi Gogineni, MD, MSHP (1) · Kirstin Williams, CNP (1) · Laura Esserman, MD, MBA (1) · Monica Rizzo, MD (1) · Norman Wolmark, MD (1)
PMID 21429799, PMID 21486711, PMID 21796368, PMID 21804697, PMID 22198468, PMID 22623692, PMID 22649152, PMID 27406346, PMID 27406347, PMID 28851423, PMID 30928806, PMID 32031889, PMID 32053137, PMID 32450725, PMID 32701140, PMID 33877311, PMID 33970392, PMID 34529000, PMID 34741021, PMID 35623341, PMID 35993306, PMID 36069821, PMID 36456573, PMID 37029329, PMID 37325931, PMID 37488289, PMID 37505107, PMID 38086377, PMID 38180338, PMID 38362377, PMID 38745646, PMID 39158353, PMID 39277671, PMID 39277672, PMID 39405911, PMID 39613746, PMID 39625569, PMID 40526879, PMID 40551254, PMID 40639409, PMID 40679371, PMID 40777112, PMID 41879562, PMID 42530945, PMID 42545411, PMID 42619946, PMID 42811224, PMID 8372225
2008 (1), 2009 (1), 2018 (1), R01CA091713 (1), R01EB002136 (1)